DaVita Inc. (NYSE:DVA) Shares Purchased by Cetera Investment Advisers

Key Points

• Cetera Investment Advisers increased its stake in DaVita Inc. by 56.9% during the first quarter, now owning 7,658 shares valued at approximately $1.17 million.
• Other institutional investors, including Northern Trust Corp and Deutsche Bank AG, have also boosted their holdings in DaVita, leading to 90.12% of the stock currently owned by institutional investors.
• DaVita recently reported an earnings per share of $2.95, surpassing estimates and showing a 6.1% revenue increase year-over-year to $3.38 billion.

Cetera Investment Advisers increased its position in DaVita Inc. (NYSE:DVA - Free Report) by 56.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,658 shares of the company's stock after buying an additional 2,778 shares during the period. Cetera Investment Advisers' holdings in DaVita were worth $1,171,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in DVA. Northern Trust Corp grew its stake in DaVita by 12.5% in the fourth quarter. Northern Trust Corp now owns 740,774 shares of the company's stock worth $110,783,000 after purchasing an additional 82,326 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in DaVita by 14.0% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 466,046 shares of the company's stock worth $69,697,000 after acquiring an additional 57,386 shares during the last quarter. Deutsche Bank AG raised its stake in DaVita by 35.2% in the 4th quarter. Deutsche Bank AG now owns 392,422 shares of the company's stock worth $58,687,000 after acquiring an additional 102,230 shares during the last quarter. Epoch Investment Partners Inc. purchased a new position in shares of DaVita during the 4th quarter valued at about $55,100,000. Finally, Iron Triangle Partners LP purchased a new position in shares of DaVita during the 4th quarter valued at about $38,946,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at DaVita

In other DaVita news, insider James O. Hearty sold 2,351 shares of the company's stock in a transaction on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the transaction, the insider owned 26,038 shares in the company, valued at $3,905,700. This represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.50% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

DVA has been the topic of several research analyst reports. Truist Financial set a $148.00 price objective on DaVita in a report on Friday, August 8th. Barclays decreased their target price on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 7th. Finally, Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a research note on Friday, April 25th.

DaVita Stock Up 0.9%

Shares of DaVita stock traded up $1.26 during trading hours on Friday, reaching $135.65. 277,424 shares of the company were exchanged, compared to its average volume of 865,189. DaVita Inc. has a 1 year low of $126.07 and a 1 year high of $179.60. The stock's fifty day moving average is $139.74 and its 200 day moving average is $145.73. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.34 and a current ratio of 1.39. The firm has a market cap of $9.70 billion, a PE ratio of 13.33, a PEG ratio of 0.96 and a beta of 1.09.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, topping analysts' consensus estimates of $2.70 by $0.25. The firm had revenue of $3.38 billion during the quarter, compared to the consensus estimate of $3.36 billion. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The company's revenue was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.00 earnings per share. As a group, equities research analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.